Found 17 matching trials
Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)
PHASE1This study will evaluate the safety, tolerability, and effect of multiple d...
Location
Multiple Locations
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
PHASE2This is a 4-week, randomized-controlled trial of suvorexant vs placebo in p...
Location
Johns Hopkins Bayview Medical Center
Suvorexant for Treatment of AUD and PTSD
PHASE2This study is to determine if suvorexant (SUV) will reduce insomnia in 76 m...
Location
University of California - Los Angeles
Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)
PHASE3This is a multicenter study to test the hypothesis that suvorexant (MK-4305...
Location
Multiple Locations
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
PHASE4Investigators propose a double-blind, placebo-controlled trial evaluating t...
Location
MUSC Department of Family Medicine
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
PHASE3People with opioid use disorder (OUD) can have trouble falling or staying a...
Location
Cenexel CNS ( Site 2012)
Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)
PHASE3This is a multicenter study to test the hypothesis that suvorexant (MK-4305...
Location
Multiple Locations
Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users
PHASE1This placebo- and active controlled study will investigate the abuse potent...
Location
Altasciences Clinical Kansas, Inc. (former Vince and Associates Clinical Research, Inc.)
A Pilot Study of Suvorexant for Insomnia in Parkinson Disease
PHASE4The purpose of this study is to see if the study drug, suvorexant, is safe ...
Location
Evergreenhealth Booth Gardner Parkinsons Care Center
Efficacy and Safety of Suvorexant (MK-4305) for Reducing Incidence of Delirium in Japanese Participants at High Risk of Delirium (MK-4305-085)
PHASE3The goal of this study is to evaluate the efficacy and safety of suvorexant...
Location
Kohnodai Hospital, National Center for Global Health and Medicine ( Site 8522)